The sensitivity of the amplification refractory mutation allele-specific polymerase chain reaction system (ARMAS-PCR) to detect known p53 mutations was determined using DNA extracted from two human tumour cell lines collected by cytobrush, as a model for its use in exfoliative cytology. Using DNA ex
Combination of enzyme analysis, allele-specific PCR and sequencing to detect mutations in theGALTgene
β Scribed by F. R. O. Calderon; L. Nelson; P. Dobrowolski; I. Sinitsyna; A. Phansalkar; N. Longo; M. Pasquali; R. Mao
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 185 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The detection of rare mutations has many important tant allele in a PCR reaction using a primer that has applications, including risk assessment of drugs and more mismatches to the wild-type allele than the chemicals, measuring environmental exposures to mutant allele. By combining these two approac
## Abstract Lowβlevel drug resistance is not detected by routine consensus sequence genotype analysis (CSA) but low levels of specific mutations, such as the nonβnucleoside reverse transcriptase inhibitor (NNRTI)βresistant mutation K103N, can be quantitated by alleleβspecific PCR (ASP). This study
A rare subgroup (approx. 5%) of all chronic granulomatous disease (CGD) patients suffers from mutations in the gene encoding the small p22-phox subunit of the flavocytochrome b558 heterodimer, the terminal redox component of the phagocyte NADPH oxidase. A male CGD patient with neutrophil granulocyte
Analysis of large genes for mutations of clinical relevance is complicated by intragenic heterogeneity, sensitivity, and cost of the methods available, and in the case of many conditions, specificity of the genetic alterations detected. We examined the FBN1 gene for mutations in people who had Marfa